ANKRD1 and ovarian carcinoma: Some of the listed transcription factors are expressed in ovarian/tumour tissues and ovarian cancer cell lines and have already been related to various aspects of ovarian cancer, including poor prognosis (LRPPRC) and sensitivity to cisplatin (ANKRD1), as shown in Table 1, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58.